McKesson (NYSE:MCK), the largest pharmaceutical distributor in North America, announced October 25 that it is acquiring PSS World Medical (Nasdaq:PSSI) for $1.62 billion ($29 a share) and the assumption of $480 million in debt. PSS World Medical competes with McKesson's Medical-Surgical unit for the business of physicians and long-term care facilities. On the surface it seems like a straightforward acquisition. How does this deal affect each group of shareholders? Who wins and who loses, if anyone?

Discount Brokers Comparison: Your one-stop shop for finding the perfect broker for your investments.

The deal is a 34% premium on PSS World Medical's closing stock price as of October 24. According to Bloomberg, McKesson is paying 11 times EBITDA, considerably less than the 15 times EBITDA paid on average for 20 similar deals since 2007. Upon completion of the acquisition, McKesson's medical-surgical business will combine with PSS World Medical under the leadership of Stanton McComb, a 10-year McKesson veteran. McKesson's medical-surgical revenue in fiscal 2012 was $3.15 billion while PSS World Medical's was slightly less at $2.1 billion. The combined $5.25 billion in revenue provides it with the scale necessary to compete with bigger distributors such as Owens & Minor (NYSE:OMI) and Henry Schein (Nasdaq:HSIC). McKesson believes that the combination will result in $100 million in pre-tax synergies within four years. Ross Muken, an analyst with International Strategy & Investment Group, believes the deal adds at least 20 cents to McKesson's full-year earnings in fiscal 2013. As of the end of September, its debt to capital ratio was 31.7%. The addition of $480 million in debt from PSS World Medical bumps that up 350 basis points to 35.2%. With $2.8 billion in cash on the balance sheet as of the second quarter, it won't have to take on any additional debt to consummate the transaction.

SEE: Analyzing An Acquisition Announcement

PSS World Medical
The usual ambulance chasers were out immediately after the deal's announcement suggesting the board breached its fiduciary duty by not shopping its business adequately enough to generate additional, superior offers. These firms forget that the business is only worth more than $29 a share if someone else is willing to pay up for the company. PSS World Medical's stock has traded above $29 just once in its 18 years as a public company and that was all the way back in May 1996. Shareholders are getting a reasonable price that erases what was a poor year on the markets (down 10.7% YTD prior to offer) up until this point; they should be thankful McKesson has come along at all.

Its interest expenses year-over-year almost doubled in the first quarter, up $4 million to $8.5 million, thanks to the issue of $250 million in senior notes in February. With a slightly lower operating margin in the first quarter, it generated pre-tax earnings of $13.2 million, 17.5% lower than in Q1 2011. Most importantly, its debt as a percentage of shareholder equity went from 61.9% in Q1 2011 to 115.6% in Q1 2012. While some of the debt was used to pay down its $127.3 million revolving line of credit and some of its 2008 notes, the remainder is for general corporate purposes including potential acquisitions. The interest rate on its 2012 notes is 6.375% compared to 3.125% for those in 2008. In the past three years it has made eight strategic acquisitions at a total cost of $146 million. Although its margins in the past few years have generally improved, being part of a company [McKesson] that has more cash than PSS World Medical has revenue, should be a game changer for its business. Shareholders can hope for a better deal but it won't come. This is as good as it gets.

SEE: Understanding The Income Statement

The Bottom Line
Mckesson's purchase of PSS World Medical is good for both groups of shareholders. McKesson gets the scale it was looking for in its medical-surgical distribution unit without overpaying and PSS World Medical gets the financial resources of a much bigger company. At $29, its shareholders make out like bandits. The only concern, as is often the case when combining businesses, is the employees. According to McKesson CEO John Hammergren in its Q2 conference call, it intends to retain all of the sales reps from both companies. That's not to suggest there won't be any staffing cuts due to overlap, but it appears that the $100 million in synergies won't come from major headcount reductions. If that's the case this is a win all the way around.

At the time of writing, Will Ashworth did not own any shares in any company mentioned in this article.

Related Articles
  1. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  2. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  3. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  4. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  6. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  7. Professionals

    What to do During a Market Correction

    The market has what? Here's what you should consider rather than panicking.
  8. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
  9. Mutual Funds & ETFs

    ETF Analysis: Schwab US Broad Market

    Take an in-depth look at the Schwab U.S. Broad Market ETF, an incredibly low-cost fund based on a wide selection of the U.S. equity market.
  10. Professionals

    Tips for Helping Clients Though Market Corrections

    When the stock market sees a steep drop, clients are bound to get anxious. Here are some tips for talking them off the ledge.
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
  6. What happens to the shares of stock purchased in a tender offer?

    The shares of stock purchased in a tender offer become the property of the purchaser. From that point forward, the purchaser, ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!